CLINICAL_TRIALS
trial_result
· 2021-09-16
Clinical Trial Update: Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder [Phase 2]
Summary
Phase 2 study of MDMA-assisted psychotherapy for posttraumatic stress disorder has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lykos Therapeutics | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-09-16